| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Pathology,*
New York University
Medical Center, New York, New York; the Istituto Nazionale Neurologico
Carlo Besta,
Milano, Italy and the Department
of Pathology and Laboratory Medicine,
Indiana
University School of Medicine, Indianapolis, Indiana
We have investigated the proteolytic cleavage of the cellular (PrPC) and pathological (PrPSc) isoforms of the human prion protein (PrP) in normal and prion-affected brains and in tonsils and platelets from neurologically intact individuals. The various PrP species were resolved after deglycosylation according to their electrophoretic mobility, immunoreactivity, Sarkosyl solubility, and, as a novel approach, resistance to endogenous proteases. First, our data show that PrPC proteolysis in brain originates amino-truncated peptides of 21 to 22 and 18 (C1) kd that are similar in different regions and are not modified by the PrP codon 129 genotype, a polymorphism that affects the expression of prion disorders. Second, this proteolytic cleavage of PrPC in brain is blocked by inhibitors of metalloproteases. Third, differences in PrPC proteolysis, and probably in Asn glycosylation and glycosylphosphatidylinositol anchor composition, exist between neural and non-neural tissues. Fourth, protease-resistant PrPSc cores in sporadic Creutzfeldt-Jakob disease (CJD) and Gerstmann-Sträussler-Scheinker F198S disease brains all have an intact C1 cleavage site (Met111-His112), which precludes disruption of a domain associated with toxicity and fibrillogenesis. Fifth, the profile of endogenous proteolytic PrPSc peptides is characteristic of each disorder studied, thus permitting the molecular classification of these prion diseases without the use of proteinase K and even a recognition of PrPSc heterogeneity within type 2 CJD patients having different codon 129 genotype and neuropathological phenotype. This does not exclude the role of additional factors in phenotypic expression; in particular, differences in glycosylation that may be especially relevant in the new variant CJD. Proteolytic processing of PrP may play an important role in the neurotropism and phenotypic expression of prion diseases, but it does not appear to participate in disease susceptibility.
This article has been cited by other articles:
 |
|
 |
|
  G Giaccone, G Di Fede, M Mangieri, L Limido, R Capobianco, S Suardi, M Grisoli, S Binelli, P Fociani, O Bugiani, et al. A novel phenotype of sporadic Creutzfeldt Jakob disease J. Neurol. Neurosurg. Psychiatry, December 1, 2007; 78(12): 1379 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Owen, H. C. Rees, B. C. Maddison, L. A. Terry, L. Thorne, R. Jackman, G. C. Whitelam, and K. C. Gough Molecular Profiling of Ovine Prion Diseases by Using Thermolysin-Resistant PrPSc and Endogenous C2 PrP Fragments J. Virol., October 1, 2007; 81(19): 10532 - 10539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. N. M. Hajj, M. H. Lopes, A. F. Mercadante, S. S. Veiga, R. B. da Silveira, T. G. Santos, K. C. B. Ribeiro, M. A. Juliano, S. G. Jacchieri, S. M. Zanata, et al. Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins J. Cell Sci., June 1, 2007; 120(11): 1915 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. M. Dlakic, E. Grigg, and R. A. Bessen Prion Infection of Muscle Cells In Vitro J. Virol., May 1, 2007; 81(9): 4615 - 4624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Huang, J. Liang, M. Zheng, X. Li, M. Wang, P. Wang, D. Vanegas, D. Wu, B. Chakraborty, A. P. Hays, et al. Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice PNAS, April 17, 2007; 104(16): 6800 - 6805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sunyach, M. A. Cisse, C. A. da Costa, B. Vincent, and F. Checler The C-terminal Products of Cellular Prion Protein Processing, C1 and C2, Exert Distinct Influence on p53-dependent Staurosporine-induced Caspase-3 Activation J. Biol. Chem., January 19, 2007; 282(3): 1956 - 1963. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Hill, S. Joiner, J. A. Beck, T. A. Campbell, A. Dickinson, M. Poulter, J. D. F. Wadsworth, and J. Collinge Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations Brain, March 1, 2006; 129(3): 676 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. T. Watt, D. R. Taylor, A. Gillott, D. A. Thomas, W. S. S. Perera, and N. M. Hooper Reactive Oxygen Species-mediated {beta}-Cleavage of the Prion Protein in the Cellular Response to Oxidative Stress J. Biol. Chem., October 28, 2005; 280(43): 35914 - 35921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Glatzel, M. H. Mohajeri, R. Poirier, R. M. Nitsch, P. Schwarz, B. Lu, and A. Aguzzi No influence of amyloid-{beta}-degrading neprilysin activity on prion pathogenesis J. Gen. Virol., June 1, 2005; 86(6): 1861 - 1867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Arima, N. Nishida, S. Sakaguchi, K. Shigematsu, R. Atarashi, N. Yamaguchi, D. Yoshikawa, J. Yoon, K. Watanabe, N. Kobayashi, et al. Biological and Biochemical Characteristics of Prion Strains Conserved in Persistently Infected Cell Cultures J. Virol., June 1, 2005; 79(11): 7104 - 7112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zanusso, A. Farinazzo, F. Prelli, M. Fiorini, M. Gelati, S. Ferrari, P. G. Righetti, N. Rizzuto, B. Frangione, and S. Monaco Identification of Distinct N-terminal Truncated Forms of Prion Protein in Different Creutzfeldt-Jakob Disease Subtypes J. Biol. Chem., September 10, 2004; 279(37): 38936 - 38942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yadavalli, R. P. Guttmann, T. Seward, A. P. Centers, R. A. Williamson, and G. C. Telling Calpain-dependent Endoproteolytic Cleavage of PrPSc Modulates Scrapie Prion Propagation J. Biol. Chem., May 21, 2004; 279(21): 21948 - 21956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Luhr, E. K. Nordstrom, P. Low, H.-G. Ljunggren, A. Taraboulos, and K. Kristensson Scrapie Protein Degradation by Cysteine Proteases in CD11c+ Dendritic Cells and GT1-1 Neuronal Cells J. Virol., May 1, 2004; 78(9): 4776 - 4782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Lawson, S. A. Priola, K. Meade-White, M. Lawson, and B. Chesebro Flexible N-terminal Region of Prion Protein Influences Conformation of Protease-resistant Prion Protein Isoforms Associated with Cross-species Scrapie Infection in Vivo and in Vitro J. Biol. Chem., April 2, 2004; 279(14): 13689 - 13695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-Q. Zou, S. Capellari, P. Parchi, M.-S. Sy, P. Gambetti, and S. G. Chen Identification of Novel Proteinase K-resistant C-terminal Fragments of PrP in Creutzfeldt-Jakob Disease J. Biol. Chem., October 17, 2003; 278(42): 40429 - 40436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Beringue, G. Mallinson, M. Kaisar, M. Tayebi, Z. Sattar, G. Jackson, D. Anstee, J. Collinge, and S. Hawke Regional heterogeneity of cellular prion protein isoforms in the mouse brain Brain, September 1, 2003; 126(9): 2065 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Kaneider, A. Kaser, S. Dunzendorfer, H. Tilg, and C. J. Wiedermann Sphingosine Kinase-Dependent Migration of Immature Dendritic Cells in Response to Neurotoxic Prion Protein Fragment J. Virol., May 1, 2003; 77(9): 5535 - 5539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Peoc'h, C. Serres, Y. Frobert, C. Martin, S. Lehmann, S. Chasseigneaux, V. Sazdovitch, J. Grassi, P. Jouannet, J.-M. Launay, et al. The Human "Prion-like" Protein Doppel Is Expressed in Both Sertoli Cells and Spermatozoa J. Biol. Chem., November 1, 2002; 277(45): 43071 - 43078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wegner, A. Romer, R. Schmalzbauer, H. Lorenz, O. Windl, and H. A. Kretzschmar Mutant prion protein acquires resistance to protease in mouse neuroblastoma cells J. Gen. Virol., May 1, 2002; 83(5): 1237 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Burthem, B. Urban, A. Pain, and D. J. Roberts The normal cellular prion protein is strongly expressed by myeloid dendritic cells Blood, December 15, 2001; 98(13): 3733 - 3738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Milhavet, H. E. M. McMahon, W. Rachidi, N. Nishida, S. Katamine, A. Mangé, M. Arlotto, D. Casanova, J. Riondel, A. Favier, et al. Prion infection impairs the cellular response to oxidative stress PNAS, November 22, 2000; (2000) 250289197. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Rossi, G. Giaccone, L. Giampaolo, S. Iussich, G. Puoti, M. Frigo, G. Cavaletti, L. Frattola, O. Bugiani, and F. Tagliavini Creutzfeldt-Jakob disease with a novel four extra-repeat insertional mutation in the PrP gene Neurology, August 8, 2000; 55(3): 405 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Vincent, E. Paitel, Y. Frobert, S. Lehmann, J. Grassi, and F. Checler Phorbol Ester-regulated Cleavage of Normal Prion Protein in HEK293 Human Cells and Murine Neurons J. Biol. Chem., November 3, 2000; 275(45): 35612 - 35616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Tagliavini, P. M.-J. Lievens, C. Tranchant, J.-M. Warter, M. Mohr, G. Giaccone, F. Perini, G. Rossi, M. Salmona, P. Piccardo, et al. A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Straussler-Scheinker Disease A117V J. Biol. Chem., February 16, 2001; 276(8): 6009 - 6015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. M. McMahon, A. Mange, N. Nishida, C. Creminon, D. Casanova, and S. Lehmann Cleavage of the Amino Terminus of the Prion Protein by Reactive Oxygen Species J. Biol. Chem., January 12, 2001; 276(3): 2286 - 2291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Milhavet, H. E. M. McMahon, W. Rachidi, N. Nishida, S. Katamine, A. Mange, M. Arlotto, D. Casanova, J. Riondel, A. Favier, et al. Prion infection impairs the cellular response to oxidative stress PNAS, December 5, 2000; 97(25): 13937 - 13942. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
